Definitive Healthcare Corp.

DH Nasdaq SEC CIK 1861795
Follow Definitive Healthcare Corp. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $54.7M −9% vs same quarter last year
Net income −$3.9M +73.8% vs same quarter last year
EPS, diluted −$0.04 +71.4% vs same quarter last year
Operating cash flow $11.4M −27.2% vs same quarter last year
Revenue by quarter
$62.3M
$59.2M
$60.8M
$60M
$61.5M
$55.9M
$55.2M
$54.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$600M−$400M−$200M$0$200M$400MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$241.5M−$138.9M
FY24$252.2M−$413.1M
FY23$251.4M−$202.4M
FY22$222.7M−$7.2M
FY21$166.2M−$17.8M
FY20$118.3M$0
FY19--
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−300%−200%−100%0%100%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2575.9%−92.9%−57.5%
FY2478.3%−281.8%−163.8%
FY2381.1%−131.2%−80.5%
FY2280.9%−19.8%−3.2%
FY2175.5%−16.4%−10.7%
FY2074.2%−13.4%0%
FY19---
FY18---
Free cash flowOperating cash flow minus capital expenditure
$0$20M$40M$60MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$37.1M
FY24$45.9M
FY23$38.2M
FY22$27.3M
FY21$18.5M
FY20$21.8M
FY19-
FY18-
Returned to shareholdersDividends paid and shares bought back
$0$20M$40M$60MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearBuybacks
FY25$49.5M
FY24$22.4M
FY23$0
FY22$0
FY21-
FY20-
FY19-
FY18-
Net margin vs the sectorMedian of Technology companies filing with the SEC
  • Definitive Healthcare Corp.
  • Technology median
−200%−150%−100%−50%0%50%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearDefinitive Healthcare Corp.Technology median
FY25−57.5%−2.4%
FY24−163.8%−5%
FY23−80.5%−6.7%
FY22−3.2%−4.4%
FY21−10.7%−1.7%
FY200%−3%
FY19-0%
FY18-0.8%